Global Keloid Treatment Market Research Report: By Product (Elastic Wraps, Ointment), by Treatment (Radiation Therapy, Cry Therapy, Surgical Treatment, Laser Treatment, Laser Treatment, Interferon), by End-User (Hospitals and Others)—Forecast till 2027
ID: MRFR/Pharma/5340-HCR | February 2021 | Region: Global | 90 pages
Market Scenario:
The global keloid treatment market is expected to reach USD 3.9 billion by 2023 and is expected to increase at a CAGR of 3.5 % during the forecast period from 2018 to 2023.
A keloid is a tough heaped-up scar that rises above the rest of the skin. It usually has a pink or purple color. Keloids have irregularly shaped scar that develops on the skin and enlarges progressively. Unlike other scars, keloids do not revert over time. According to the US national library of medicine, keloid formation is seen in individuals of all ages but dark-skinned people are more susceptible to keloid scar and about 6% to 16% in African populations is suffering from keloid skin problems.
The global keloid treatment market is expected to grow due to rapid development made in technological skin care products. Also growing awareness among people regarding the availability of treatment options and other products available to cure keloid is growing the keloid treatment market. Additionally, rising expenditure on skin care product, services and changing lifestyle have also significantly contributed to the expansion of keloid treatment market. However growing consciousness among patients particularly females regarding their appearance is also driving the market. As there is an increasing demand for keloid treatment, clinics and hospitals are focusing on adoption of advanced therapy options. Recently Sensus Healthcare has come up with a superficial radiation therapy device to provide better treatment with limited adverse reactions.
However, this market is being hindered by the possible side effects of keloid treatment, the high cost of various treatment options, and the risk of pain and barriers during treatment.
Key players:
Some of the key players in the global keloid treatment market are Novartis AG, RXi Pharmaceuticals, Inc., Sonoma Pharmaceuticals, Inc., Bristol-Myers Squibb Company, Pacific World Corporation, Valeant Pharmaceuticals International, Inc., Revitol Corporation, Avita Medical Limited, Sensus Healthcare, Perrigo Company plc.
Intended Audience
- Manufacturers and Suppliers
- Dermatology Hospitals and Clinics
- Dermatology laboratories and associations
- Research and development centers
Market Segmentation:
The global keloid treatment market is segmented into product type, treatment, and end-users.
Based on product type the market is segmented into elastic wraps, spray, ointment, creams, oils, topical gels & gel sheets.
Based on treatment market for keloid has been segmented into ligature, radiation therapy, cry therapy, surgical treatment, laser treatment, steroid injections, corticosteroid injections (intralesional steroids), silicone gel or sheeting, occlusive dressing, compression therapy, and interferon. Corticosteroid injections treatment segments lead the global keloid treatment market as this treatment is used in combination with other therapies. Intralesional steroids injection is considered to be the second largest segment of treatment type that drives market.
On the basis of end-users, the keloid treatment market is segmented into dermatology clinics, hospitals, ambulatory surgical centers. Hospital is expected to hold the largest share in the segment market of end-users as most doctors prefer radiation therapy which has reported safe and effective use of radiation to treat keloid.
The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The keloid treatment market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.
The European keloid treatment market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.
The keloid treatment market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The keloid treatment market in the Middle East & Africa has been segmented into the Middle East and Africa.
Regional Market Summary
Geographically, North America dominates the global keloid treatment market and is expected to continue to dominate the market throughout the forecast period. Clinics in North America are adopting advanced technologies for the treatment of keloid. Development of new technologies, product, alternative treatment and high disposable income of people in this region is responsible for the rapid growth of the keloid treatment market in this region.
Europe is the second largest market in the globe owing to the increasing awareness among people, favorable reimbursement scenario for skin treatment, increasing government expenditure for skin care product, the presence of disposable income and increasing demand for the cosmetic product.
Asia-Pacific is anticipated to be the fastest growing market owing to the growing prevalence of skin caries, increased focus on appearance and aesthetic in the developing countries, rising population, increasing disposable income, and growing healthcare expenditure are anticipated to increase the keloid treatment market in Asia-Pacific.
The Middle East & Africa is expected to account for the lowest market share in the global keloid treatment market due to low development, lack of technical knowledge, and poor medical facilities in developing economies in this region.
Global Keloid Treatment Market Share (%), by Region, 2017 
Source: Food and Drug Administration (FDA), Centers for Disease Control and Prevention (CDC), American College of Prosthodontists
Global Keloid Treatment Market, by Product Type
- Elastic Wraps
- Sprays
- Ointment
- Creams
- Oils
- Topical Gels & Gel Sheets
Global Keloid Treatment Market, by Treatment
- Ligature
- Radiation Therapy
- Cry Therapy
- Surgical Treatment
- Laser Treatment
- Steroid Injections
- Corticosteroid injections (intralesional steroids)
- Silicone gel or sheeting
- Interferon
Global Keloid Treatment Market, by End User
- Dermatology clinics
- Hospitals
- Ambulatory surgical centers
- Others
Global Keloid Treatment Market, by Region
- Americas
- North America
- US
- Canada
- South America
- North America
- Europe
- Western Europe
- Germany
- France
- Italy
- Spain
- UK
- Rest of Western Europe
- Eastern Europe
- Western Europe
- Asia Pacific
- Japan
- China
- India
- Australia
- Republic of Korea
- Rest of Asia Pacific
- Middle East & Africa
- Middle East
- Africa
Frequently Asked Questions (FAQ) :
The global keloid market is expected to reach a valuation of USD 3.9 billion by 2023.
The market is expected to exhibit a strong 3.5% CAGR over the forecast period from 2020-2027.
The rapid rise in the technological scenario behind skin care products is the major driver for the global keloid treatment market.
North America is the dominant regional market for keloid treatment.
Leading players in the keloid treatment market include Valeant, RXi Pharmaceuticals, Novartis, and Pacific World Corporation, among others.
Table of Contents:
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope of the Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
Chapter 5. Market Factor Analysis
5.1 Porter’s Five Forces Analysis
5.1.1 Bargaining Power of Suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of New Entrants
5.1.4 Threat of Substitutes
5.1.5 Intensity of Rivalry
5.2 Value Chain Analysis
5.3 Investment Feasibility Analysis
5.4 Pricing Analysis
Chapter 6. Global Keloid Treatment Market, by Product
6.1 Introduction
6.2 Elastic Wraps
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
6.4 Sprays
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
6.5 Ointment
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
6.6 Creams
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
6.7 Oils
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
6.8 Topical Gels & Gel Sheets
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
Chapter 7. Global Keloid Treatment Market, by Treatment
7.1 Introduction
7.2 Ligature
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
7.3 Radiation Therapy
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
7.4 Cryo Therapy
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
7.5 Surgical Treatment
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
7.6 Laser Treatment
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
7.7 Steroid Injections
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
7.8 Corticosteroid injections (intralesional steroids)
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
7.9 Silicone gel or sheeting
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
7.10 Interferon
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
Chapter 8. Global Keloid Treatment Market, by End User
8.1 Introduction
8.2 Dermatology Clinics
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
8.3 Hospitals
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
8.4 Ambulatory Surgical Centers
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
Chapter 9. Global Keloid Treatment Market, by Region
9.1 Introduction
9.2 Americas
9.2.1 North America
9.2.1.1 US
9.2.1.2 Canada
9.2.2 South America
9.3 Europe
9.3.1 Western Europe
9.3.1.1 Germany
9.3.1.2 France
9.3.1.3 Italy
9.3.1.4 Spain
9.3.1.5 UK
9.3.1.6 Rest of Western Europe
9.3.2 Eastern Europe
9.4 Asia-Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.4.6 Rest of Asia-Pacific
9.5 Middle East & Africa
9.5.1 Middle East
9.5.2 Africa
Chapter 10. Company Landscape
10.1 Introduction
10.2 Market Share Analysis
10.3 Key Development & Strategies
Chapter 11. Company Profiles
11.1 Novartis AG
11.1.1 Company Overview
11.1.2 Product Overview
11.1.3 Financials Overview
11.1.4 Key Developments
11.1.5 SWOT Analysis
11.2 RXi Pharmaceuticals, Inc
11.2.1 Company Overview
11.2.2 Product Overview
11.2.3 Financial Overview
11.2.4 Key Developments
11.2.5 SWOT Analysis
11.3 Sonoma Pharmaceuticals, Inc
11.3.1 Company Overview
11.3.2 Product Overview
11.3.3 Financial Overview
11.3.4 Key Development
11.3.5 SWOT Analysis
11.4 Bristol-Myers Squibb
11.4.1 Company Overview
11.4.2 Product Overview
11.4.3 Financial Overview
11.4.4 Key Development
11.4.5 SWOT Analysis
11.5 Pacific World Corporation
11.5.1 Company Overview
11.5.2 Product Overview
11.5.3 Financial overview
11.5.4 Key Developments
11.5.5 SWOT Analysis
11.6 Valeant Pharmaceuticals International, Inc
11.6.1 Company Overview
11.6.2 Product Overview
11.6.3 Financial Overview
11.6.4 Key Developments
11.6.5 SWOT Analysis
11.7 Revitol Corporation
11.7.1 Overview
11.7.2 Product Overview
11.7.3 Financial Overview
11.7.4 Key Developments
11.7.5 SWOT Analysis
11.8 Avita Medical Limited
11.8.1 Overview
11.8.2 Product Overview
11.8.3 Financials
11.8.4 Key Developments
11.8.5 SWOT Analysis
11.8 Sensus Healthcare
11.8.1 Overview
11.8.2 Product Overview
11.8.3 Financials
11.8.4 Key Developments
11.8.5 SWOT Analysis
11.9 Perrigo Company plc
11.9.1 Overview
11.9.2 Product Overview
11.9.3 Financials
11.9.4 Key Developments
11.9.5 SWOT Analysis
Chapter 12 MRFR Conclusion
12.1 Key Findings
12.1.1 From CEO’s Viewpoint
12.1.2 Unmet Needs of the Market
12.2 Key Companies to Watch
12.3 Predictions for the Keloid Treatment Industry
Chapter 13. Appendix
LIST OF TABLES
Table 1 Global Keloid Treatment Market Synopsis, 2020–2027
Table 2 Global Keloid Treatment Market Estimates and Forecast, 2020–2027
(USD Million)
Table 3 Global Keloid Treatment Market, by Region, 2020–2027 (USD Million)
Table 4 Global Keloid Treatment Market, by Product, 2020–2027 (USD Million)
Table 5 Global Keloid Treatment Market, by Treatment, 2020–2027(USD Million)
Table 6 Global Keloid Treatment Market, by End User, 2020–2027 (USD Million)
Table 7 North America: Keloid Treatment Market, by Product, 2020–2027 (USD Million)
Table 8 North America: Keloid Treatment Market, by Treatment, 2020–2027 (USD Million)
Table 9 North America: Keloid Treatment Market, by End User, 2020–2027 (USD Million)
Table 10 US: Keloid Treatment Market, by Product, 2020–2027 (USD Million)
Table 11 US: Keloid Treatment Market, by Treatment, 2020–2027 (USD Million)
Table 12 US: Keloid Treatment Market, by End User, 2020–2027 (USD Million)
Table 13 Canada: Keloid Treatment Market, by Product, 2020–2027 (USD Million)
Table 14 Canada: Keloid Treatment Market, by Treatment, 2020–2027 (USD Million)
Table 15 Canada: Keloid Treatment Market, by End User, 2020–2027 (USD Million)
Table 16 South America: Keloid Treatment Market, by Product, 2020–2027 (USD
Million)
Table 17 South America: Keloid Treatment Market, by Treatment, 2020–2027 (USD Million)
Table 18 South America: Keloid Treatment Market, by End User, 2020–2027 (USD Million)
Table 19 Europe: Keloid Treatment Market, by Product, 2020–2027 (USD Million)
Table 20 Europe: Keloid Treatment Market, by Treatment, 2020–2027 (USD Million)
Table 21 Europe: Keloid Treatment Market, by End User, 2020–2027 (USD Million)
Table 22 Western Europe: Keloid Treatment Market, by Product, 2020–2027 (USD Million)
Table 23 Western Europe: Keloid Treatment Market, by Treatment, 2020–2027 (USD Million)
Table 24 Western Europe: Keloid Treatment Market, by End User, 2020–2027 (USD Million)
Table 25 Eastern Europe: Keloid Treatment Market, by Product, 2020–2027 (USD Million)
Table 26 Eastern Europe: Keloid Treatment Market, by Treatment, 2020–2027 (USD Million)
Table 27 Eastern Europe: Keloid Treatment Market, by End User, 2020–2027(USD Million)
Table 28 Asia-Pacific: Keloid Treatment Market, by Product, 2020–2027 (USD Million)
Table 29 Asia-Pacific: Keloid Treatment Market, by Treatment, 2020–2027 (USD Million)
Table 30 Asia-Pacific: Keloid Treatment Market, by End User, 2020–2027 (USD Million)
Table 31 Middle East & Africa: Keloid Treatment Market, by Product, 2020–2027 (USD Million)
Table 32 Middle East & Africa: Keloid Treatment Market, by Treatment, 2020–2027 (USD Million)
Table 33 Middle East & Africa: Keloid Treatment Market, by End User, 2020–2027 (USD Million)
LIST OF FIGURES
Figure 1 Research Process
Figure 2 Segmentation for Global Keloid Treatment Market
Figure 3 Segmentation Market Dynamics for Global Keloid Treatment Market
Figure 4 Global Keloid Treatment Market Share, by Product, 2020
Figure 5 Global Keloid Treatment Market Share, by Treatment, 2020
Figure 6 Global Keloid Treatment Market Share, by End User, 2020
Figure 7 Global Keloid Treatment Market Share, by Region, 2020
Figure 8 North America: Keloid Treatment Market Share, by Country, 2020
Figure 9 Europe: Keloid Treatment Market Share, by Country, 2020
Figure 10 Asia-Pacific: Keloid Treatment Market Share, by Country, 2020
Figure 11 Middle East & Africa: Keloid Treatment Market Share, by Country, 2020
Figure 12 Global Keloid Treatment Market: Company Share Analysis, 2020 (%)
Figure 13 Novartis AG: Key Financials
Figure 14 Novartis AG: Segmental Revenue
Figure 15 Novartis AG: Geographical Revenue
Figure 16 RXi Pharmaceuticals, Inc: Key Financials
Figure 17 RXi Pharmaceuticals, Inc: Segmental Revenue
Figure 18 RXi Pharmaceuticals, Inc: Geographical Revenue
Figure 19 Sonoma Pharmaceuticals, Inc: Key Financials
Figure 20 Sonoma Pharmaceuticals, Inc: Segmental Revenue
Figure 21 Sonoma Pharmaceuticals, Inc: Geographical Revenue
Figure 22 Bristol-Myers Squibb : Key Financials
Figure 23 Bristol-Myers Squibb : Segmental Revenue
Figure 24 Bristol-Myers Squibb : Geographical Revenue
Figure 25 Pacific World Corporation: Key Financials
Figure 26 Pacific World Corporation: Segmental Revenue
Figure 27 Pacific World Corporation. Geographical Revenue
Figure 28 Valeant Pharmaceuticals International, Inc: Key Financials
Figure 29 Valeant Pharmaceuticals International, Inc: Segmental Revenue
Figure 30 Valeant Pharmaceuticals International, Inc: Geographical Revenue
Figure 31 Revitol Corporation: Key Financials
Figure 32 Revitol Corporation: Segmental Revenue
Figure 33 Revitol Corporation: Geographical Revenue
Figure 34 Avita Medical Limited: Key Financials
Figure 35 Avita Medical Limited: Segmental Revenue
Figure 36 Avita Medical Limited: Geographical Revenue
Figure 37 Sensus Healthcare: Key Financials
Figure 38 Sensus Healthcare: Segmental Revenue
Figure 39 Sensus Healthcare: Geographical Revenue
Figure 40 Perrigo Company plc: Key Financials
Figure 41 Perrigo Company plc: Segmental Revenue
Figure 42 Perrigo Company plc: Geographical Revenue